Carregant...
Determinants of Androgen Deprivation Therapy Use for Prostate Cancer: Role of the Urologist
BACKGROUND: The use of androgen deprivation therapy for prostate cancer has been increasing, even in settings for which there is weak or no evidence of efficacy. This pattern suggests that factors other than the typical patient and tumor characteristics may be driving its use. We assessed the import...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2006
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1853355/ https://ncbi.nlm.nih.gov/pubmed/16788157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djj230 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|